Deutsche Bank’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $515K | Buy |
90,237
+9,597
| +12% | +$43.6K | ﹤0.01% | 2759 |
|
|
2026
Q1 | $363K | Sell |
80,640
-42,543
| -35% | -$222K | ﹤0.01% | 2738 |
|
|
2025
Q4 | $758K | Sell |
123,183
-276,308
| -69% | -$2M | ﹤0.01% | 2347 |
|
|
2025
Q3 | $2.89M | Buy |
399,491
+342,820
| +605% | +$2.04M | ﹤0.01% | 1566 |
|
|
2025
Q2 | $301K | Sell |
56,671
-15,281
| -21% | -$90.3K | ﹤0.01% | 2733 |
|
|
2025
Q1 | $638K | Sell |
71,952
-7,445
| -9% | -$89.4K | ﹤0.01% | 2374 |
|
|
2024
Q4 | $1.09M | Buy |
79,397
+27,541
| +53% | +$508K | ﹤0.01% | 2195 |
|
|
2024
Q3 | $1.42M | Buy |
51,856
+11,664
| +29% | +$316K | ﹤0.01% | 1956 |
|
|
2024
Q2 | $983K | Sell |
40,192
-3,202
| -7% | -$70.3K | ﹤0.01% | 1997 |
|
|
2024
Q1 | $925K | Buy |
43,394
+2,795
| +7% | +$60.1K | ﹤0.01% | 2052 |
|
|
2023
Q4 | $777K | Sell |
40,599
-829
| -2% | -$14.3K | ﹤0.01% | 2156 |
|
|
2023
Q3 | $665K | Buy |
41,428
+2,622
| +7% | +$49.9K | ﹤0.01% | 1980 |
|
|
2023
Q2 | $900K | Sell |
38,806
-23,750
| -38% | -$518K | ﹤0.01% | 2052 |
|
|
2023
Q1 | $1.45M | Sell |
62,556
-18,607
| -23% | -$378K | ﹤0.01% | 1868 |
|
|
2022
Q4 | $1.18M | Buy |
81,163
+10,742
| +15% | +$200K | ﹤0.01% | 1947 |
|
|
2022
Q3 | $1.34M | Sell |
70,421
-8,292
| -11% | -$190K | ﹤0.01% | 1806 |
|
|
2022
Q2 | $1.43M | Sell |
78,713
-66,806
| -46% | -$1.39M | ﹤0.01% | 1954 |
|
|
2022
Q1 | $3.67M | Sell |
145,519
-3,356
| -2% | -$85.9K | ﹤0.01% | 1541 |
|
|
2021
Q4 | $4.11M | Buy |
148,875
+63,016
| +73% | +$1.83M | ﹤0.01% | 1550 |
|
|
2021
Q3 | $2.77M | Sell |
85,859
-785
| -0.9% | -$26.1K | ﹤0.01% | 1868 |
|
|
2021
Q2 | $2.65M | Buy |
86,644
+389
| +0.5% | +$11.2K | ﹤0.01% | 1972 |
|
|
2021
Q1 | $2.63M | Sell |
86,255
-11,384
| -12% | -$323K | ﹤0.01% | 1967 |
|
|
2020
Q4 | $1.93M | Buy |
97,639
+13,355
| +16% | +$216K | ﹤0.01% | 1960 |
|
|
2020
Q3 | $1.1M | Buy |
84,284
+24,194
| +40% | +$306K | ﹤0.01% | 2129 |
|
|
2020
Q2 | $681K | Sell |
60,090
-213,614
| -78% | -$3.03M | ﹤0.01% | 2457 |
|
|
2020
Q1 | $3.92M | Sell |
273,704
-2,433,922
| -90% | -$51.4M | ﹤0.01% | 1376 |
|
|
2019
Q4 | $73.7M | Buy |
2,707,626
+2,615,041
| +2,824% | +$71.9M | 0.05% | 378 |
|
|
2019
Q3 | $2.65M | Sell |
92,585
-110,267
| -54% | -$3.21M | ﹤0.01% | 1753 |
|
|
2019
Q2 | $5.63M | Buy |
202,852
+172,431
| +567% | +$4.87M | ﹤0.01% | 1738 |
|
|
2019
Q1 | $1.01M | Sell |
30,421
-8,620
| -22% | -$262K | ﹤0.01% | 2987 |
|
|
2018
Q4 | $1.13M | Sell |
39,041
-275,586
| -88% | -$9.91M | ﹤0.01% | 2794 |
|
|
2018
Q3 | $14.5M | Buy |
314,627
+33,408
| +12% | +$1.49M | 0.01% | 1341 |
|
|
2018
Q2 | $10.5M | Sell |
281,219
-18,952
| -6% | -$640K | 0.01% | 1702 |
|
|
2018
Q1 | $8.87M | Buy |
300,171
+61,020
| +26% | +$2.06M | ﹤0.01% | 1725 |
|
|
2017
Q4 | $8.21M | Sell |
239,151
-292,466
| -55% | -$9.87M | 0.01% | 1645 |
|
|
2017
Q3 | $19.2M | Buy |
531,617
+341,788
| +180% | +$9.75M | 0.01% | 1062 |
|
|
2017
Q2 | $4.9M | Sell |
189,829
-39,072
| -17% | -$829K | ﹤0.01% | 1933 |
|
|
2017
Q1 | $4.39M | Sell |
228,901
-842,870
| -79% | -$14.9M | ﹤0.01% | 1753 |
|
|
2016
Q4 | $17.9M | Sell |
1,071,771
-182,207
| -15% | -$3.3M | 0.01% | 926 |
|
|
2016
Q3 | $25.8M | Buy |
1,253,978
+903,761
| +258% | +$22.9M | 0.02% | 792 |
|
|
2016
Q2 | $10.7M | Buy |
350,217
+139,843
| +66% | +$4.86M | 0.01% | 1260 |
|
|
2016
Q1 | $7.87M | Buy |
210,374
+159,193
| +311% | +$6M | 0.01% | 1423 |
|
|
2015
Q4 | $2.21M | Buy |
51,181
+9,321
| +22% | +$394K | ﹤0.01% | 2370 |
|
|
2015
Q3 | $1.56M | Sell |
41,860
-29,297
| -41% | -$1.04M | ﹤0.01% | 2643 |
|
|
2015
Q2 | $2.41M | Buy |
71,157
+26,856
| +61% | +$913K | ﹤0.01% | 2307 |
|
|
2015
Q1 | $1.57M | Sell |
44,301
-5,592
| -11% | -$200K | ﹤0.01% | 2610 |
|
|
2014
Q4 | $1.7M | Sell |
49,893
-145,850
| -75% | -$5.18M | ﹤0.01% | 2794 |
|
|
2014
Q3 | $7.54M | Buy |
195,743
+12,368
| +7% | +$461K | ﹤0.01% | 1547 |
|
|
2014
Q2 | $7.13M | Sell |
183,375
-333,858
| -65% | -$12.4M | ﹤0.01% | 1570 |
|
|
2014
Q1 | $17.7M | Sell |
517,233
-150,052
| -22% | -$4.65M | 0.01% | 989 |
|
|
2013
Q4 | $14M | Sell |
667,285
-501,837
| -43% | -$12.7M | 0.01% | 1129 |
|
|
2013
Q3 | $27.5M | Buy |
1,169,122
+761,601
| +187% | +$21.6M | 0.02% | 740 |
|
|
2013
Q2 | $10.9M | Buy |
+407,521
| New | +$11.8M | 0.01% | 1185 |
|
Other funds holding MYGN
VPC
Deutsche Bank's MYGN Position: Q2 2026 in Review
Deutsche Bank increased its Myriad Genetics (MYGN) stake by 12% in Q2 2026, buying an estimated $43.6K and bringing the position to 90,237 shares worth $515K. The position accounts for ﹤0.01% of the portfolio, ranked #2759.
Deutsche Bank first reported a position in MYGN in Q2 2013 and has held it in 53 quarters since. The position peaked at $73.7M in Q4 2019. 196 funds tracked by Wall St. Rank hold MYGN as of Q2 2026.
- Deutsche Bank held 90,237 shares of Myriad Genetics worth $515K as of Q2 2026.
- Deutsche Bank bought 9,597 Myriad Genetics shares in Q2 2026, an estimated $43.6K.
- Myriad Genetics made up ﹤0.01% of Deutsche Bank's portfolio in Q2 2026, its #2759 holding.
- Deutsche Bank first reported a position in Myriad Genetics in Q2 2013 and has held it in 53 quarters since.
- Deutsche Bank's Myriad Genetics position peaked at $73.7M in Q4 2019.
- 196 funds tracked by Wall St. Rank held Myriad Genetics as of Q2 2026.
Based on Deutsche Bank's 13F filing for Q2 2026, filed 7 Aug 2026.